| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
1,644 |
1,559 |
$3.06M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,102 |
3,954 |
$298K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,549 |
5,400 |
$292K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,480 |
1,420 |
$166K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,650 |
1,549 |
$127K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,828 |
2,672 |
$60K |
| J3262 |
Injection, tocilizumab, 1 mg |
20 |
12 |
$36K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
411 |
410 |
$31K |
| 99243 |
|
221 |
221 |
$16K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
254 |
240 |
$2K |
| 99442 |
|
53 |
52 |
$1K |
| 96415 |
|
65 |
64 |
$1K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
140 |
132 |
$479.81 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
205 |
198 |
$318.58 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
31 |
31 |
$196.47 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
14 |
14 |
$104.16 |
| 99441 |
|
55 |
55 |
$0.00 |